Mines D'Or Orbec Inc. (BLUE)
Jun 2, 2025 - BLUE was delisted (reason: acquired by Carlyle and SK Capital)
4.970
0.00 (0.00%)
Inactive · Last trade price on May 30, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Gene Therapies
29.07M
Gene Therapies Growth
961.15%
Other
432.00K
Other Growth
-49.65%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
29.50M
United States Growth
720.04%